🔗 Share this article

While the United States proceeds with unprecedented revisions to its vaccination recommendations, an unexpected name has emerged somewhat surprisingly: Høeg, a US-based physician and epidemiologist who first made her name by questioning Covid shots in the pandemic and has concentrated on alleged fatalities after Covid immunization in her short position at the Food and Drug Administration.

Planned Shifts to Childhood Vaccine Program

Health officials were set to reveal radical revisions to the childhood vaccine schedule earlier this month, synchronizing the US with the Danish national calendar, it is understood – a major change that would place the US out of alignment with a large portion of the global community with insufficient data for benefit. This reveal has been pushed back until the coming year.

Rather than the top vaccines chief, Dr. Høeg is listed to speak at the event. She was just designated temporary leader of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth person to head the center this year.

A New Direction at the Regulatory Body

Høeg's temporary position might represent a closer partnership between the pharmaceutical and vaccine divisions as Høeg and Prasad consolidate power at the regulatory agency – and it points to a renewed priority upon dismantling already-approved immunizations at the FDA.

Høeg has frequently advocated for discontinuing certain pediatric immunization guidelines in the US to become more like the Danish model, a nation with universal health coverage and a population roughly the size of the state of Wisconsin.

In her initial public appearances, she has kept her attention on immunizations – typically the responsibility of Dr. Prasad, chief of the FDA’s CBER – as opposed to medication approval.

Doubts Over Qualifications

Høeg has little discernible track record in medication creation, approval processes or leadership, which has been standard for past directors of the CBER. She has worked at the FDA as a top consultant to the FDA chief and the vaccine center since earlier this year.

“It seems she lacks to have any of the qualifications” for leading the CDER, said Jonathan Howard. “She’s never run a scientific study. She has no expertise in leading a major agency. She is not an expert in drug approvals.”

Previous heads of CBER would “grasp laws and regulations and the underlying principles of medication creation”, said Janet Woodcock. “Frankly, she has not acquired the kind of background that prior appointees who headed the center have had.”

This division has an vast portfolio at the agency, the former commissioner pointed out.

“Many people just zeroes in on the new drug program, but the generic program approves thousands of generic medications. There’s a biologic copycat branch, OTC medication office and so forth, and each of these need to be managed,” she explained. “The responsibility you don’t keep your eye on, that is precisely what that I always told people is going to cause problems.”

Additionally, a substantial administrative aspect to the position, which oversees more than 5,000 staff members. “It is a enormous administrative position, if you do it right,” she concluded.

Official Statement and Disputed Programs

When asked about questions about Dr. Høeg's credentials and whether this assignment signifies increased cooperation among FDA leaders on vaccines, a press secretary responded that the “questions stem from inaccurate assumptions”.

“This background matches the functions of her position,” the spokesperson stated, noting the period Dr. Høeg spent counseling the agency head on “medication safety and regulatory science, including computerized risk analysis and shot safety tracking”.

As the temporary head, Dr. Høeg inherits the commissioner’s controversial expedited review system, a controversial one-day drug-approval program that allegedly worried her former heads. “How are these medications being picked for this voucher program? Who is making the decisions?” Dr. Howard said. “There’s a lot of confidentiality occurring at the agency right now.”

Broadly speaking, he remarked, “the Food and Drug Administration appears to be shifting towards less stringent rules of most medications, with the exception of immunizations.”

Established History on Immunizations

With immunizations, Høeg has a more established, if concerning, history, critics said. She published a study using unverified crowd-sourced reports to determine the rate of myocarditis following Covid immunization. She consulted for the Florida chief medical officer Dr. Joseph Ladapo, who reportedly have altered data to imply Covid vaccines are pose a greater threat than they are.

Among her “policy goals” for the current federal leadership included revising guidelines for novel immunizations and halting “non-essential” vaccines, she remarked post-election on a online show. At the agency, Dr. Høeg has according to sources floated the idea of excluding young men from obtaining Covid vaccines.

“She is an all-around dogmatist who begins with her preconceived notions and reverse-engineers to accommodate the data in a extremely misleading, dishonest fashion,” Dr. Howard stated.

Consolidating Power and a “Push for Payback”

Høeg aligned with other contrarians, {like|